Compare Sana Biotechnology Inc (SANA) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs ProShares UltraPro Short QQQ ETF — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while ProShares UltraPro Short QQQ ETF trades at $40.47. Which is the better fit depends on your goals.
| SANA | SQQQ | |
|---|---|---|
Market Cap | $873.84M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $5.92 | $97.60 |
52-Week Low | $2.68 | $36.31 |
Enterprise Value | $848.03M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
